These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 31077012)
1. Estrogen-independent role of ERα in ovarian cancer progression induced by leptin/Ob-Rb axis. Ghasemi A; Saeidi J; Mohtashami M; Hashemy SI Mol Cell Biochem; 2019 Aug; 458(1-2):207-217. PubMed ID: 31077012 [TBL] [Abstract][Full Text] [Related]
2. Leptin induces matrix metalloproteinase 7 expression to promote ovarian cancer cell invasion by activating ERK and JNK pathways. Ghasemi A; Hashemy SI; Aghaei M; Panjehpour M J Cell Biochem; 2018 Feb; 119(2):2333-2344. PubMed ID: 28885729 [TBL] [Abstract][Full Text] [Related]
3. RhoA/ROCK pathway mediates leptin-induced uPA expression to promote cell invasion in ovarian cancer cells. Ghasemi A; Hashemy SI; Aghaei M; Panjehpour M Cell Signal; 2017 Apr; 32():104-114. PubMed ID: 28104444 [TBL] [Abstract][Full Text] [Related]
4. Estradiol promotes cell survival and induces Greb1 expression in granulosa cell tumors of the ovary through an ERα-dependent mechanism. Cluzet V; Devillers MM; Petit F; Pierre A; Giton F; Airaud E; L'Hôte D; Leary A; Genestie C; Treilleux I; Mayeur A; Katzenellenbogen JA; Kim SH; Cohen-Tannoudji J; Chauvin S; Guigon CJ J Pathol; 2022 Mar; 256(3):335-348. PubMed ID: 34860414 [TBL] [Abstract][Full Text] [Related]
5. Effects of oestrogen on long noncoding RNA expression in oestrogen receptor alpha-positive ovarian cancer cells. Qiu J; Ye L; Ding J; Feng W; Zhang Y; Lv T; Wang J; Hua K J Steroid Biochem Mol Biol; 2014 May; 141():60-70. PubMed ID: 24380700 [TBL] [Abstract][Full Text] [Related]
6. Stage specific effect of leptin on the expressions of estrogen receptor and extracellular matrix in a model of chondrocyte differentiation. Li XF; Wang SJ; Jiang LS; Dai LY Cytokine; 2013 Mar; 61(3):876-84. PubMed ID: 23357303 [TBL] [Abstract][Full Text] [Related]
7. Role of GPER on proliferation, migration and invasion in ligand-independent manner in human ovarian cancer cell line SKOV3. Yan Y; Jiang X; Zhao Y; Wen H; Liu G Cell Biochem Funct; 2015 Dec; 33(8):552-9. PubMed ID: 26526233 [TBL] [Abstract][Full Text] [Related]
8. Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic setting. Fusco R; Galgani M; Procaccini C; Franco R; Pirozzi G; Fucci L; Laccetti P; Matarese G Endocr Relat Cancer; 2010 Jun; 17(2):373-82. PubMed ID: 20410173 [TBL] [Abstract][Full Text] [Related]
9. Superactive human leptin antagonist (SHLA), triple Lan1 and quadruple Lan2 leptin mutein as a promising treatment for human folliculoma. Fiedor E; Gregoraszczuk EL Cancer Chemother Pharmacol; 2017 Oct; 80(4):815-827. PubMed ID: 28861689 [TBL] [Abstract][Full Text] [Related]
10. Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer. Chen X; Zha X; Chen W; Zhu T; Qiu J; Røe OD; Li J; Wang Z; Yin Y Biomed Pharmacother; 2013 Feb; 67(1):22-30. PubMed ID: 23199901 [TBL] [Abstract][Full Text] [Related]
11. Differential induction of LRP16 by liganded and unliganded estrogen receptor alpha in SKOV3 ovarian carcinoma cells. Tian L; Wu Z; Zhao Y; Meng Y; Si Y; Fu X; Mu Y; Han W J Endocrinol; 2009 Jul; 202(1):167-77. PubMed ID: 19403568 [TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor alpha pathway is involved in leptin-induced ovarian cancer cell growth. Choi JH; Lee KT; Leung PC Carcinogenesis; 2011 Apr; 32(4):589-96. PubMed ID: 21173433 [TBL] [Abstract][Full Text] [Related]
14. Activation of estrogen receptor α by estradiol and cisplatin induces platinum-resistance in ovarian cancer cells. Matsumura S; Ohta T; Yamanouchi K; Liu Z; Sudo T; Kojimahara T; Seino M; Narumi M; Tsutsumi S; Takahashi T; Takahashi K; Kurachi H; Nagase S Cancer Biol Ther; 2017 Sep; 18(9):730-739. PubMed ID: 27689466 [TBL] [Abstract][Full Text] [Related]
15. Expression and clinical significance of estrogen-regulated long non-coding RNAs in estrogen receptor α-positive ovarian cancer progression. Qiu JJ; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ Oncol Rep; 2014 Apr; 31(4):1613-22. PubMed ID: 24481591 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis. Chan KKL; Siu MKY; Jiang YX; Wang JJ; Wang Y; Leung THY; Liu SS; Cheung ANY; Ngan HYS BMC Cancer; 2017 Aug; 17(1):606. PubMed ID: 28859612 [TBL] [Abstract][Full Text] [Related]
17. The expression and correlation between the transcription factor FOXP1 and estrogen receptors in epithelial ovarian cancer. Hu Z; Zhu L; Tan M; Cai M; Deng L; Yu G; Liu D; Liu J; Lin B Biochimie; 2015 Feb; 109():42-8. PubMed ID: 25500588 [TBL] [Abstract][Full Text] [Related]
18. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer. Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091 [TBL] [Abstract][Full Text] [Related]
19. microRNA-206 overexpression inhibits cellular proliferation and invasion of estrogen receptor α-positive ovarian cancer cells. Li S; Li Y; Wen Z; Kong F; Guan X; Liu W Mol Med Rep; 2014 May; 9(5):1703-8. PubMed ID: 24604205 [TBL] [Abstract][Full Text] [Related]
20. Role of estrogen receptor-alpha and -beta in regulating leptin expression in 3T3-L1 adipocytes. Yi KW; Shin JH; Seo HS; Lee JK; Oh MJ; Kim T; Saw HS; Kim SH; Hur JY Obesity (Silver Spring); 2008 Nov; 16(11):2393-9. PubMed ID: 18719660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]